Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rebmann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|January 17, 2002
Immune response to perforated and partially demineralized bone allograftsK U Lewandrowski, V Rebmann, M Pässler, et al.
Tissue Antigens|August 2, 2003
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2X Wang, B Liang, V Rebmann, et al.
Vox Sanguinis|April 15, 2000
Therapeutic immunoadsorption increases the level of circulating soluble HLA moleculesD Poehlau, U Kiltz, M Rieks, et al.
Tissue Antigens|March 11, 2004
Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitisA Heiligenhaus, V Rebmann, A Neubert, et al.
Leukemia|April 30, 2010
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaH Nückel, M Switala, L Sellmann, et al.
Human Immunology|May 29, 2000
Soluble HLA levels in early pregnancy after in vitro fertilizationK A Pfeiffer, V Rebmann, M Pässler, et al.
Tissue Antigens|January 6, 2001
Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopesL A Verbruggen, N Dumarey, H Van de Velde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chainsS A Desai, X Wang, E J Noronha, et al.
Annals of Surgery|February 19, 1999
HLA-DR expression and soluble HLA-DR levels in septic patients after traumaM Ditschkowski, E Kreuzfelder, V Rebmann, et al.
Leukemia|January 22, 2014
MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host diseaseL Kordelas, V Rebmann, A-K Ludwig, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|January 17, 2002
Immune response to perforated and partially demineralized bone allograftsK U Lewandrowski, V Rebmann, M Pässler, et al.
Tissue Antigens|August 2, 2003
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2X Wang, B Liang, V Rebmann, et al.
Vox Sanguinis|April 15, 2000
Therapeutic immunoadsorption increases the level of circulating soluble HLA moleculesD Poehlau, U Kiltz, M Rieks, et al.
Tissue Antigens|March 11, 2004
Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitisA Heiligenhaus, V Rebmann, A Neubert, et al.
Leukemia|April 30, 2010
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaH Nückel, M Switala, L Sellmann, et al.
Human Immunology|May 29, 2000
Soluble HLA levels in early pregnancy after in vitro fertilizationK A Pfeiffer, V Rebmann, M Pässler, et al.
Tissue Antigens|January 6, 2001
Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopesL A Verbruggen, N Dumarey, H Van de Velde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chainsS A Desai, X Wang, E J Noronha, et al.
Annals of Surgery|February 19, 1999
HLA-DR expression and soluble HLA-DR levels in septic patients after traumaM Ditschkowski, E Kreuzfelder, V Rebmann, et al.
Leukemia|January 22, 2014
MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host diseaseL Kordelas, V Rebmann, A-K Ludwig, et al.
Pageof 4